The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMediumUpdated×3•Originally published 6 May 2026•Updated 8 May 2026•

1 min read

Strong Q1 Results: US Companies Raise Full-Year 2026 Guidance

Key Facts

1Elanco raised its full-year 2026 revenue guidance to between $5,010 million and $5,085 million.

2TG Therapeutics reported Q1 global revenue of $205 million and raised its BRIUMVI U.S. net product revenue target.

27 days ago

Version History

Version 327 days ago

What changed: Added Emera Inc. results, which reported a 7% EPS increase and raised its annualized earnings growth expectations above the previous target range.

Version 227 days ago

What changed: Added Q1 financial metrics for Pembina Pipeline, including cash flow figures and a dividend increase.

Version 128 days ago

What changed: Added Q1 financial results and improved cash flow guidance for Athabasca Oil to the report.

The Q1 2026 earnings season continues with positive momentum as major corporations report robust financial performance and raised outlooks. Emera Inc. bolstered this trend, reporting an adjusted EPS of $1.37 compared to $1.28 in the previous year, while confirming that annualized earnings growth will exceed its 5-7% target range. Pembina Pipeline also recorded adjusted cash flow of $790 million and increased its quarterly dividend, while Elanco Animal Health raised its full-year revenue guidance. In the energy sector, Athabasca Oil increased its cash flow outlook for 2026, and TG Therapeutics reported global revenues of $205 million. Additionally, NiSource Inc. posted a solid net income of $510.7 million. These upward revisions across the energy, utilities, and healthcare sectors suggest resilient momentum and sustained growth potential for the fiscal year.